vimarsana.com

Page 20 - ஸிம்மர் பயோமெட் ஹோல்டிங்ஸ் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Spine Devices Market to Reach US$ 8,348 2 Million Revenue by 2022 end – KSU

Global Spine Devices Market to Reach US$ 8,348 2 Million Revenue by 2022 end – KSU
ksusentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksusentinel.com Daily Mail and Mail on Sunday newspapers.

Zimmer Biomet Holdings Inc (ZBH) Q1 2021 Earnings Call Transcript

Zimmer sees strong 1st quarter | Business | The Journal Gazette

Zimmer sees strong 1st quarter Earnings rise $700 million SHERRY SLATER | The Journal Gazette Zimmer Biomet Holdings Inc. on Tuesday reported first-quarter earnings of $198 million, or 94 cents per diluted common share, an increase of more than $700 million from the loss of $509 million, or $2.46 a share, in the first three months of 2020. The Warsaw-based orthopedic devices manufacturer also reported net sales of $1.85 billion for the period ended March 31, a 4% increase from the same period last year. Bryan Hanson, Zimmer Biomet s president and CEO, said the company s first-quarter performance was stronger than anticipated and aided by the vaccine rollout. “As we move into the second quarter, we expect that momentum to continue and believe we are well-positioned to meet the needs of our customers as elective procedures return,” he said in a statement.

Zimmer Biomet Holdings Inc Q1 adjusted earnings of $1 71 per share

Zimmer Biomet Holdings Inc. Q1 adjusted earnings of $1.71 per share WASHINGTON (dpa-AFX) - Below are the earnings highlights for Zimmer Biomet Holdings Inc. (ZBH): -Earnings: $198.1 million in Q1 vs. -$508.5 million in the same period last year. -EPS: $0.94 in Q1 vs. -$2.46 in the same period last year. -Excluding items, Zimmer Biomet Holdings Inc. reported adjusted earnings of $359.1 million or $1.71 per share for the period. -Revenue: $1.85 billion in Q1 vs. $1.78 billion in the same period last year. -Guidance: Full year EPS guidance: $7.60 - $8.00 Copyright RTT News/dpa-AFX © 2021 AFX News

Zimmer Biomet Announces First Quarter 2021 Financial Results and Full Year Revenue Outlook

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2021. The Company reported first quarter net sales of $1.847 billion, an increase of 3.6% over the prior year period, and an increase of 0.8% on a constant currency basis. Net earnings for the first quarter were $198.1 million, or $359.1 million on an adjusted basis.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.